Botulinum toxin treatment of spastic equinus in cerebral palsy: a randomized trial comparing two injection sites

Area of Science:

• Pediatric Neurology
• Rehabilitation Medicine
• Movement Disorders

Background:

• Spastic equinus gait is a common challenge in children with cerebral palsy.
• Botulinum toxin A injections are frequently used to manage this condition.
• The optimal injection site for botulinum toxin A in the gastrocnemius muscle is debated.

Purpose of the Study:

• To compare the clinical effectiveness of proximal versus distal botulinum toxin A injection sites in the gastrocnemius muscle.
• To evaluate the impact of injection site on gait parameters and muscle function in children with cerebral palsy.
• To determine the clinical relevance of altering the injection site for managing spastic equinus gait.

Main Methods:

• A randomized study involving 19 children with cerebral palsy and spastic equinus gait.
• Participants received botulinum toxin A injections either proximally or distally into the gastrocnemius muscle.
• Outcome measures included range of motion, muscle tone, and video gait analysis assessed pre- and post-treatment.

Main Results:

• Both injection techniques improved active/passive dorsiflexion and calf tone.
• The distal injection group showed statistically significant improvements in Observational Gait Scale scores at 8 weeks.
• However, the overall clinical relevance of these differences between injection sites was considered tenuous.

Conclusions:

• Changing the botulinum toxin A injection site from proximal to distal in the gastrocnemius muscle did not lead to major changes in main outcome measures.
• The study suggests that current injection site variations may have limited clinical impact on managing spastic equinus gait in this population.
• Further research may be needed to identify more impactful treatment strategies for this condition.